Savara Inc (SVRA)
4.81
+0.01
(+0.21%)
USD |
NASDAQ |
Apr 19, 16:00
4.81
0.00 (0.00%)
After-Hours: 19:14
Savara Cash from Financing (Quarterly): 7.895M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.895M |
| September 30, 2023 | 74.76M |
| June 30, 2023 | 0.104M |
| March 31, 2023 | 0.026M |
| December 31, 2022 | 0.001M |
| September 30, 2022 | -0.001M |
| June 30, 2022 | 0.088M |
| March 31, 2022 | -0.001M |
| December 31, 2021 | 0.006M |
| September 30, 2021 | 0.01M |
| June 30, 2021 | 0.324M |
| March 31, 2021 | 120.47M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 1.827M |
| June 30, 2020 | 2.328M |
| March 31, 2020 | -0.466M |
| December 31, 2019 | 25.25M |
| September 30, 2019 | 5.708M |
| June 30, 2019 | 19.06M |
| March 31, 2019 | 4.896M |
| December 31, 2018 | 9.096M |
| September 30, 2018 | 45.81M |
| June 30, 2018 | 0.016M |
| March 31, 2018 | 0.271M |
| December 31, 2017 | 50.76M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.435M |
| June 30, 2017 | 54.90M |
| March 31, 2017 | |
| December 31, 2016 | 0.10M |
| September 30, 2016 | 4.321M |
| June 30, 2016 | -6.723M |
| March 31, 2016 | 7.419M |
| December 31, 2015 | -8.073M |
| September 30, 2015 | 14.82M |
| June 30, 2015 | 2.034M |
| March 31, 2015 | -0.006M |
| December 31, 2014 | 20.24M |
| September 30, 2014 | 2.17M |
| June 30, 2014 | 3.901M |
| March 31, 2014 | 7.978M |
| December 31, 2013 | -0.1163M |
| September 30, 2013 | -0.2426M |
| June 30, 2013 | 26.10M |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.0007M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 15.64M |
| September 30, 2011 | 0.00 |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.466M
Minimum
Mar 2020
120.47M
Maximum
Mar 2021
13.55M
Average
0.104M
Median
Jun 2023
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.026M |
| Palatin Technologies Inc | 4.974M |
| iBio Inc | 4.005M |
| Theriva Biologics Inc | -1.457M |
| Ampio Pharmaceuticals Inc | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.60M |
| Cash from Investing (Quarterly) | 6.571M |
| Free Cash Flow | -51.36M |
| Free Cash Flow Per Share (Quarterly) | -0.0843 |
| Free Cash Flow Yield | -6.52% |